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Graves disease (GD) is a common autoimmune thyroid disorder that is inherited as a complex multigenic trait. By
using a single microsatellite marker at each locus, we screened the type 1 diabetes loci IDDM4, IDDM5, IDDM6,
IDDM8, and IDDM10 and the fucosyltransferase-2 locus for linkage in sib pairs with GD. This showed a two-
point nonparametric linkage (NPL) score of 1.57 ( ) at the IDDM6 marker D18S41, but NPL scores wereP = .06
!1.0 at the other five loci. Thus, the investigation of the IDDM6 locus was extended by genotyping 11 microsatellite
markers spanning 48 cM across chromosome 18q12-q22 in 81 sib pairs affected with autoimmune thyroid disease
(AITD). Multipoint analysis, designating all AITD sib pairs as affected, showed a peak NPL score of 3.46 (P =
), at the marker D18S487. Designation of only GD cases as affected (74 sib pairs) showed a peak NPL score.0003
of 3.09 ( ). Linkage to this region has been demonstrated in type 1 diabetes (IDDM6), rheumatoid arthritis,P = .001
and systemic lupus erythematosus, which suggests that this locus may have a role in several forms of autoimmunity.
Graves disease (GD) (MIM 275000) is a common organ-
specific autoimmune disorder, in which hyperthyroidism
occurs because of the stimulation of the thyrotropin re-
ceptor by a thyroid-stimulating autoantibody. There is
a strong genetic component in the pathogenesis of GD,
with an estimated ls of 10–15 (Brix et al. 1998). Recent
linkage and family-based association studies of GD have
identified several susceptibility loci at different chro-
mosomal regions—including 6p21 (major histocompat-
ibility complex [MHC]) (Heward et al. 1998; Vaidya et
al. 1999), 2q33 (cytotoxic T lymphocyte antigen-4
[CTLA-4]) (Heward et al. 1999; Vaidya et al. 1999),
14q31 (GD-1) (Tomer et al. 1998a), 20q13 (GD-2) (To-
mer et al. 1998b; Pearce et al. 1999), and Xq21 (GD-
3) (Barbesino et al. 1998)—providing evidence that GD,
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like most autoimmune diseases, is inherited as a complex
multigenic trait.
An excess concurrence of GD and type 1 diabetes
(IDDM) in the same patients or their relatives suggests
that IDDM and GD could share some susceptibility al-
leles (Payami et al. 1989). Indeed, recent studies have
demonstrated that the MHC and CTLA-4 loci are linked
to both IDDM and GD (Davies et al. 1994; Nistico` et
al. 1996; Marron et al. 1997; Heward et al. 1998, 1999;
Vaidya et al. 1999). Genomewide linkage scans for
IDDM have revealed many different chromosomal
regions of linkage, and several of these loci have been
replicated in further data sets (Davies et al. 1994; Hash-
imoto et al. 1994; Concannon et al. 1998; Mein et al.
1998). Replication of such a result in a different but
pathogenically allied disorder would provide indepen-
dent confirmation of the linkage. Thus, we screened the
following putative IDDM loci in multiplex GD families
for linkage: IDDM4 (11q13), IDDM5 (6q25), IDDM6
(18q21), IDDM8 (6q27), and IDDM10 (10p11–q11)
(Davies et al. 1994, 1996; Hashimoto et al. 1994; Luo
et al. 1996; Delepine et al. 1997; Merriman et al. 1997,
1998; Reed et al. 1997; Concannon et al. 1998; Mein
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Table 1
Phenotypes of Sib Pairs with AITD
Sib Pairs
with GD
Only
(GD–GD)
Sib Pairs
with GD
and AH
(GD–AH)a
All Sib Pairs
with AITD
Full sib pairs 69 7 76
Half sib pairs 5 0 5
Total 74b 7 81
a Families were selected only if they had at least two
sibs with GD. Seven of these families had additional sibs
with AH (GD-AH sib pairs).
b Seventy-one sib pairs with GD were available at the
time of preliminary two-point linkage analysis.
Table 2
Two-Point Linkage Analysis at the Various Candidate Loci in
Families with GD
Locus Chromosome Marker
NPL
score P
Information
Content
IDDM4 11q13 D11S1917 2.62 .73 .40
IDDM5 6q25 ESR .91 .18 .64
IDDM6 18q21 D18S41 1.57 .06 .44
IDDM8 6q27 D6S281 .48 .31 .58
IDDM10 10p11-q11 D10S193 21.05 .85 .61
FUT-2 19q13 D19S888 2.85 .80 .62
Table 3
Intrafamilial Association between Probands with GD and Unaffected Sib Controls at
Chromosome 18q12-q22 Markers
Marker
Marker Map
(cM) Allele (mu)
Probands
with GDa
Sibs Unaffected
with GDa P Corrected Pb
D18S57 .0 107 9/7 5/11 .143 .429
D18S470 12.0 289 4/4 0/8 .038 .114
D18S487 18.4 119 14/10 6/18 .020 .020
D18S41 22.7 203 19/11 16/14 .300 )
D18S1144 24.8 165 3/5 1/7 .285 )
D18S64 28.3 207 6/6 2/10 .096 .288
D18S1134 31.8 213 22/14 16/20 .118 .354
D18S1147 34.9 213 9/9 3/15 .038 .114
bcl-2 37.7 195 13/5 10/8 .244 )
D18S465 40.8 239 7/5 1/11 .014 .042
D18S485 47.8 183 13/11 7/17 .071 .213
a Number of occurrences/nonoccurrences of candidate alleles (Curtis 1997). Totals of the can-
didate alleles differentially occurring in the probands and in the unaffected siblings were compared.
b Fisher’s exact test, corrected for multiple allelic comparisons. The three most common alleles
were tested for association, but not at marker D18S487, where a candidate allele was already
known (Merriman 1997).
et al. 1998; Nakagawa et al. 1998). Studies have shown
that inability to secrete the soluble glycoprotein forms
of the ABH blood group antigens (nonsecretor pheno-
type) is also associated with IDDM and GD (Blackwell
et al. 1987; Collier et al. 1988). In whites this trait is
due to a common nonsense mutation of the fucosyl-
transferase-2 (FUT-2) gene (Kelly et al. 1995), located
on chromosome 19q13, which suggests that markers
close to this locus may also be linked to these disorders.
We have, therefore, examined linkage of GD to the
marker D19S888, which is within 1 cM of the FUT-2
locus.
Sixty-seven white families with two or more sibs af-
fected with GD (including 152 individuals with GD [26
males], 22 with autoimmune hypothyroidism [AH], and
73 unaffected subjects) were recruited from the north of
England and the Lothian region of Scotland (table 1).
Parents ( ) and unaffected sibs ( ) were stud-n = 49 n = 37
ied if available. The diagnostic criteria for GD and the
characteristics of these families have been described else-
where (Vaidya et al. 1999).
We screened the cohort of sib pairs affected with GD
(71 sib pairs available at the time of screening) (table 1)
for linkage to the single markers at IDDM4, IDDM5,
IDDM6, IDDM8, IDDM10, and FUT-2. This showed
a two-point nonparametric linkage (NPL) score of 1.57
( ) at the IDDM6 marker D18S41. NPL scoresP = .06
were all !1.0 at the other five loci (table 2). Thus, we
extended linkage analysis of the IDDM6 region by ge-
notyping 10 additional microsatellite markers (a total of
11 markers), spanning a 48-cM region of chromosome
18q12-q22. Multipoint linkage analysis in the cohort of
81 sib pairs affected with autoimmune thyroid disease
(AITD) (table 1) showed a peak NPL score of 3.46
( ), at the marker D18S487 (fig. 1). The des-P = .0003
ignation of only subjects with GD as “affected” (74 sib
pairs) showed a peak NPL score of 3.09 ( ) (fig.P = .001
1). The proportion of the 76 full sibs with AITD sharing
zero alleles (z0) reached a minimum of 0.137 close to
marker D18S487, which suggests that the locus-specific
ls for this region is 1.8. The 26 families with affected
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Figure 1 Multipoint linkage analysis of 11 markers on chro-
mosome 18q12-q23. A, Percent information content over the marker
map. B, The NPL score obtained by “scoring all” affected subjects
with GD (solid line) and AITD (broken line) with the use of the GENE-
HUNTER package (Kruglyak et al. 1996) is shown, against the marker
map on the x-axis. The peak NPL score of 3.46 occurs at marker
D18S487. The microsatellite markers were genotyped with the use of
fluorescently-labeled PCR and resolved on a semiautomated 373 ABI
sequencer. The primers were taken from the Genethon genetic linkage
map, except for bcl-2 (Mehrian et al. 1998). The marker map was
derived from the Genetic Location Database and the Center for Med-
ical Genetics–Marshfield Medical Research Foundation databases. The
minimum proportion of full sib pairs sharing zero alleles (z0) was
calculated with the use of MAPMAKER/SIBS (Kruglyak and Lander
1995). The population allele frequencies for each marker were derived
by genotyping local white controls.
AITD males (brother-sister sib pairs) showed a peak NPL
of 2.03 ( , , ls = 1.5), compared withP = .02 z0 = 0.172
3.20 ( , , ) in the 41 familiesP = .0008 z0 = 0.058 l = 4.3s
with only affected females.
To assess potential interactions between the chro-
mosome 18 locus and other putative GD loci in our
population, we weighted data from the chromosome 18
markers for allele-sharing status (0 or 1 to model epis-
tasis; 1 or 0 to model heterogeneity) at D2S117 (CTLA-
4) and TNFa (MHC), using the modified GENE-
HUNTER-plus version 2, as described (Kong and Cox
1997; Cox et al. 1999). Weighting the chromosome 18
data for allele sharing at D2S117 under a heterogeneity
model showed a peak NPL score of 2.92 ( , 32P = .002
families), which was similar to the NPL of 3.09 obtained
in the whole cohort before weighting. No other evidence
of interaction between the chromosome 18 locus and
CTLA-4 or MHC loci was found.
Family-based association analysis, with the use of un-
affected sibs as controls (Curtis 1997), showed an excess
of the 119 mobility unit (mu) allele of D18S487 (P =
) in probands with GD (table 3), which is the same.020
allele found to be associated with IDDM (Merriman et
al. 1997; T. Merriman, personal communication). This
association of GD with the 119 mu allele of D18S487
was also observed in a population-based case-control
study with 166 unrelated probands with GD and 165
controls (27.3% vs. 17.3% in controls, ).P = .002
The present study has identified a susceptibility locus
for GD at chromosome 18q21, which is close to the
IDDM6 locus. Using a multiplicative model, we can es-
timate that with a ls value of 1.8, the chromosome 18
locus may confer <25% of the total genetic suscepti-
bility to GD in our population (Risch 1987). With both
intrafamilial and population-based association analyses,
we also found weak evidence for an association of GD
with the 119 mu allele of D18S487. Our data provide
some evidence to support genetic heterogeneity between
the chromosome 18 locus and CTLA-4 in our cohort,
which suggests that these susceptibility loci may play
complementary roles in conferring susceptibility to GD
in different families.
One genomewide linkage scan involving 56 AITD
families has not found evidence for linkage to this region
of chromosome 18 (Tomer et al. 1999). However, our
study and other studies showing linkage of this chro-
mosomal region to other autoimmune diseases, such as
IDDM (IDDM6) (Davies et al. 1994; Merriman et al.
1997, 1998), rheumatoid arthritis (Cornelis et al. 1998),
and systemic lupus erythematosus (Shai et al. 1999),
provides evidence that this region is likely to harbor an
important autoimmunity locus. Candidate genes close to
the region of association include the immunoglobulin
gene transcription factor ITF2 and the MAP kinase
MAPK4, with the anti-apoptotic bcl2 gene being located
∼10cM from the region of strongest linkage. In addition,
our findings further strengthen the hypothesis that com-
mon susceptibility loci are involved in different auto-
immune disorders.
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